Yucui Jin

101 Longmian Avenue
Nanjing, 211166, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

Journal: Seminars in oncology
Published: October 01, 2025

NSUN2-mediated m5C modification of KDM6B mRNA enhances osteoclast differentiation and promotes breast cancer bone metastasis.

NSUN2-mediated m5C modification of KDM6B mRNA enhances osteoclast differentiation and promotes breast cancer bone metastasis.

Journal: Cancer letters
Published: June 03, 2025

A Circadian Rhythm-related Signature to Predict Prognosis, Immune Infiltration, and Drug Response in Breast Cancer.

A Circadian Rhythm-related Signature to Predict Prognosis, Immune Infiltration, and Drug Response in Breast Cancer.

Journal: Current medicinal chemistry
Published: April 03, 2024

KMT2D-mediated H3K4me1 recruits YBX1 to facilitate triple-negative breast cancer progression through epigenetic activation of c-Myc.

KMT2D-mediated H3K4me1 recruits YBX1 to facilitate triple-negative breast cancer progression through epigenetic activation of c-Myc.

Journal: Clinical and translational medicine
Published: March 24, 2024

EBF2 Links KMT2D-Mediated H3K4me1 to Suppress Pancreatic Cancer Progression via Upregulating KLLN.

EBF2 Links KMT2D-Mediated H3K4me1 to Suppress Pancreatic Cancer Progression via Upregulating KLLN.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 29, 2023

Editorial: Viral infection, tumor development and host immune response.

Editorial: Viral infection, tumor development and host immune response.

Journal: Frontiers in cellular and infection microbiology
Published: March 01, 2023

METTL3-mediated m6A modification of IGFBP7-OT promotes osteoarthritis progression by regulating the DNMT1/DNMT3a-IGFBP7 axis.

METTL3-mediated m6A modification of IGFBP7-OT promotes osteoarthritis progression by regulating the DNMT1/DNMT3a-IGFBP7 axis.

Journal: Cell reports
Published: September 30, 2022

ALKBH5-mediated m6A demethylation of HS3ST3B1-IT1 prevents osteoarthritis progression.

ALKBH5-mediated m6A demethylation of HS3ST3B1-IT1 prevents osteoarthritis progression.

Journal: iScience
Published: September 15, 2022

MiR-224-5p inhibits osteoblast differentiation and impairs bone formation by targeting Runx2 and Sp7.

MiR-224-5p inhibits osteoblast differentiation and impairs bone formation by targeting Runx2 and Sp7.

Journal: Cytotechnology
Published: August 17, 2022

YTHDF2-mediated FGF14-AS2 decay promotes osteolytic metastasis of breast cancer by enhancing RUNX2 mRNA translation.

YTHDF2-mediated FGF14-AS2 decay promotes osteolytic metastasis of breast cancer by enhancing RUNX2 mRNA translation.

Journal: British journal of cancer
Published: May 15, 2022

TFPI inhibits breast cancer progression by suppressing ERK/p38 MAPK signaling pathway.

TFPI inhibits breast cancer progression by suppressing ERK/p38 MAPK signaling pathway.

Journal: Genes & genomics
Published: September 30, 2021

m6A-mediated upregulation of AC008 promotes osteoarthritis progression through the miR-328-3p‒AQP1/ANKH axis.

m6A-mediated upregulation of AC008 promotes osteoarthritis progression through the miR-328-3p‒AQP1/ANKH axis.

Journal: Experimental & molecular medicine
Published: April 24, 2021
Showing 1-12 of 24

Last Updated: 09/26/2026